CLINICAL_TRIALS trial_result · 2012-09-06

Clinical Trial Update: Cetuximab as Therapy for Recurrent Non-Small Cell Lung Cancer Patients Who Have Received Prior Therapy [Phase 2]

A Phase 2 trial evaluating cetuximab for recurrent non-small cell lung cancer after prior therapy was terminated, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Lecia V. Sequist | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: TERMINATED | Results posted: 2012-09-06